Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Transplant of serologic A1 but genotype A2 kidneys to ABO O and B recipients is feasible and safe.

Human immunology - 1 Jul 2026

Thalji Nassir M, Kapturczak Matthias, Shaker Tamer, Chand Ranjeeta, Lane William J, Murphey Cathi

Abstract excerpt

BACKGROUND: Kidney transplants from ABO A2 donors to O and B recipients reduce wait times without compromising outcomes. Recent work shows that ABO genotyping more accurately identifies A2 donors than serologic methods. Here, we show that kidneys from donors labeled A1 by serology but genotyped as A2 can be safely transplanted to O and B recipients with favorable outcomes, expanding access for disadvantaged...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ABO Blood-Group System
Share to Blood Group Incompatibility

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Graft Rejection

Share to Graft Survival

Share to Kidney

Share to Kidney Transplantation

Share to Tissue Donors

Source

Identifiers

PMID: 42091020
DOI: 10.1016/j.humimm.2026.111743

Genes

ABO

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Transplant of serologic A1 but genotype A2 kidneys to ABO O and B recipients is feasible and safe.PMID 42091020Read ↗

ABO Genotyping finds more A2 to B kidney transplant opportunities than lectin-based subtyping.Semantic proximity Read ↗

Discrepant subtyping of blood type A2 living kidney donors: Missed opportunities in kidney transplantationSemantic proximity Read ↗

Feasibility and utility of a rapid ABO genotyping platform in transplantation and transfusion medicine.Semantic proximity Read ↗

Clinical Applicability of 2-Field High-Resolution and Extended HLA-Allele Typing in Deceased Donor Kidney Allocation.Semantic proximity Read ↗

A rapid and reliable PCR method for genotyping the ABO blood group. II: A2 and O2 alleles.Semantic proximity Read ↗

Clinical and Histological Phenotypes of Antibody-Mediated Rejection in Kidney Transplant: A Single-Center Experience from Latin America.Semantic proximity Read ↗

Effect of Donor and Recipient ABH-Secretor Status on ABO-Incompatible Living Donor Kidney Transplantation.Semantic proximity Read ↗

From educational to graded: Redefining proficiency testing in ABO genotyping.Semantic proximity Read ↗

The increasing need for ABO blood group genotyping and quality assurance implications for laboratory implementation.Semantic proximity Read ↗

The Potential Significance of ABO Genotyping for Donor Selection in Kidney Transplantation.Semantic proximity Read ↗

Deceased donor ABO discrepancy due to a rare AwB subgroup: Implications for organ allocation.Semantic proximity Read ↗

African American living-kidney donors should be screened for APOL1 risk alleles.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.